Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

NCT00118014 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00118014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00118014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2000
Completion date
August 31, 2004
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impulse control disorders